Capital Analysts LLC’s Avita Medical RCEL Stock Holding History

Capital Analysts LLC’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3K	Hold	652	–	–	﹤0.01%	1442
2026 Q1	$2K	Hold	652	–	–	﹤0.01%	1465
2025 Q4	$2K	Hold	652	–	–	﹤0.01%	1422
2025 Q3	$3K	Hold	652	–	–	﹤0.01%	1352
2025 Q2	$3K	Hold	652	–	–	﹤0.01%	1302
2025 Q1	$5K	Hold	652	–	–	﹤0.01%	1230
2024 Q4	$8K	Hold	652	–	–	﹤0.01%	1106
2024 Q3	$7K	Hold	652	–	–	﹤0.01%	1090
2024 Q2	$5K	Hold	652	–	–	﹤0.01%	1048
2024 Q1	$10K	Hold	652	–	–	﹤0.01%	925
2023 Q4	$9K	Hold	652	–	–	﹤0.01%	910
2023 Q3	$10K	Hold	652	–	–	﹤0.01%	884
2023 Q2	$11K	Hold	652	–	–	﹤0.01%	810
2023 Q1	$9K	Hold	652	–	–	﹤0.01%	817
2022 Q4	$4K	Hold	652	–	–	﹤0.01%	939
2022 Q3	$3K	Hold	652	–	–	﹤0.01%	957
2022 Q2	$3K	Hold	652	–	–	﹤0.01%	925
2022 Q1	$6K	Hold	652	–	–	﹤0.01%	805
2021 Q4	$8K	Hold	652	–	–	﹤0.01%	840
2021 Q3	$12K	Hold	652	–	–	﹤0.01%	772
2021 Q2	$13K	Hold	652	–	–	﹤0.01%	714
2021 Q1	$13K	Buy	+652	New	+$15.2K	﹤0.01%	764

Other funds holding RCEL

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Analysts LLC's RCEL Position: Q2 2026 in Review

Capital Analysts LLC held its Avita Medical (RCEL) position steady in Q2 2026 at 652 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Capital Analysts LLC first reported a position in RCEL in Q1 2021 and has held it in 22 quarters since. The position peaked at $13K in Q2 2021. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

Capital Analysts LLC held 652 shares of Avita Medical worth $3K as of Q2 2026.
Capital Analysts LLC left its Avita Medical share count unchanged in Q2 2026.
Avita Medical made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1442 holding.
Capital Analysts LLC first reported a position in Avita Medical in Q1 2021 and has held it in 22 quarters since.
Capital Analysts LLC's Avita Medical position peaked at $13K in Q2 2021.
74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.